Showing results (81-90 of 99) with videos related to
Sort By:
Pageof 10
Microbiome|April 12, 2022
Gut microbiome signatures linked to HIV-1 reservoir size and viremia controlAlessandra Borgognone, Marc Noguera-Julian, Bruna Oriol, et al.Eclinicalmedicine|July 18, 2019
Therapeutic Vaccination Refocuses T-cell Responses Towards Conserved Regions of HIV-1 in Early Treated Individuals (BCN 01 study)Beatriz Mothe, Christian Manzardo, Alvaro Sanchez-Bernabeu, et al.Nature Medicine|October 27, 2022
Safety, immunogenicity and effect on viral rebound of HTI vaccines in early treated HIV-1 infection: a randomized, placebo-controlled phase 1 trialLucia Bailón, Anuska Llano, Samandhy Cedeño, et al.Mucosal Immunology|September 2, 2018
Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infectionYolanda Guillén, Marc Noguera-Julian, Javier Rivera, et al.Nature Communications|January 31, 2026
Safety and biologic activity of a bispecific T cell receptor targeting HIV Gag in males living with HIV: a first-in-human trialLinos Vandekerckhove, Julie Fox, Borja Mora-Peris, et al.Ebiomedicine|April 15, 2016
Gut Microbiota Linked to Sexual Preference and HIV InfectionMarc Noguera-Julian, Muntsa Rocafort, Yolanda Guillén, et al.Ebiomedicine|March 24, 2022
Epigenetic landscape in the kick-and-kill therapeutic vaccine BCN02 clinical trial is associated with antiretroviral treatment interruption (ATI) outcomeBruna Oriol-Tordera, Anna Esteve-Codina, María Berdasco, et al.Communications Biology|November 25, 2025
Anti-SARS-CoV-2 antibodies from severe COVID-19 individuals or S2 immunizations do not worsen disease in hamstersNúria Pedreño-López, Ferran Tarrés-Freixas, Carla Usai, et al.Frontiers in Immunology|May 22, 2020
HIVconsv Vaccines and Romidepsin in Early-Treated HIV-1-Infected Individuals: Safety, Immunogenicity and Effect on the Viral Reservoir (Study BCN02)Beatriz Mothe, Miriam Rosás-Umbert, Pep Coll, et al.Journal of Virology|January 31, 2023
Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological DysfunctionClara Duran-Castells, Anuska Llano, Ai Kawana-Tachikawa, et al.Pageof 10